Evaluating prediction of short‐term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population‐based study

Documenti analoghi

• Treatment outcomes with oral anti‐hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population‐based cohort study
  di: Rhian Hopkins, et al.
  Pubblicazione: (2025)
• Higher Body Mass Index Is a Causal Risk Factor for Skin Infections: A Mendelian Randomisation Study Using UK Biobank and FinnGen
  di: Rhian Hopkins, et al.
  Pubblicazione: (2026)
• One‐year usage patterns of SGLT ‐2 inhibitors and GLP ‐1 receptor agonists in individuals with type 2 diabetes in a real‐world population
  di: Louise A. Donnelly, et al.
  Pubblicazione: (2025)
• Ten‐year progression of obesity‐related complications in a population with overweight and obesity in the UK : A retrospective open cohort study
  di: Jonathan Pearson‐Stuttard, et al.
  Pubblicazione: (2024)
• Variations in healthcare costs by body mass index and obesity‐related complications in a UK population: A retrospective open cohort study
  di: Jonathan Pearson‐Stuttard, et al.
  Pubblicazione: (2024)